metyrapol has been researched along with dicumarol in 1 studies
| Studies (metyrapol) | Trials (metyrapol) | Recent Studies (post-2010) (metyrapol) | Studies (dicumarol) | Trials (dicumarol) | Recent Studies (post-2010) (dicumarol) |
|---|---|---|---|---|---|
| 18 | 0 | 1 | 2,260 | 33 | 110 |
| Protein | Taxonomy | metyrapol (IC50) | dicumarol (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0026 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
| NAD | Homo sapiens (human) | 0.2585 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 4.426 | |
| Proprotein convertase subtilisin/kexin type 7 | Homo sapiens (human) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gebel, T; Maser, E; Netter, KJ | 1 |
1 other study(ies) available for metyrapol and dicumarol
| Article | Year |
|---|---|
Carbonyl reduction of metyrapone in human liver.
Topics: Alcohol Oxidoreductases; Dicumarol; Dihydrotestosterone; Female; Humans; Immune Sera; Immunoblotting; Indomethacin; Liver; Male; Metyrapone; Oxidation-Reduction; Quercetin; Subcellular Fractions | 1991 |